SAMUEL MEYERS: Open Payments
NPI 1750067070 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,762 in 136 payments from 22 companies in 2025. Trend: 2023 $598 · 2024 $2,667 · 2025 $3,762
Food & beverage: $2,662Travel & lodging: $1,100
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 15 | $1,544 |
| PFIZER INC. | 15 | $261 |
| Amgen Inc. | 15 | $216 |
| AstraZeneca Pharmaceuticals LP | 11 | $209 |
| E.R. Squibb & Sons, L.L.C. | 11 | $206 |
| Novartis Pharmaceuticals Corporation | 20 | $199 |
| Actelion Pharmaceuticals US, Inc. | 3 | $152 |
| Lilly USA, LLC | 8 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $107 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $105 |
Products named: VENASEAL, REPATHA, CAMZYOS, LEQVIO, VYNDAQEL, UPTRAVI, JARDIANCE, FARXIGA.
Industry payments across VA — which companies pay providers there.
